Active forgetting and neuropsychiatric diseases

Jacob A. Berry,Dana C. Guhle,Ronald L. Davis

DOI: https://doi.org/10.1038/s41380-024-02521-9

IF: 11

2024-03-27

Molecular Psychiatry

Abstract:Recent and pioneering animal research has revealed the brain utilizes a variety of molecular, cellular, and network-level mechanisms used to forget memories in a process referred to as "active forgetting". Active forgetting increases behavioral flexibility and removes irrelevant information. Individuals with impaired active forgetting mechanisms can experience intrusive memories, distressing thoughts, and unwanted impulses that occur in neuropsychiatric diseases. The current evidence indicates that active forgetting mechanisms degrade, or mask, molecular and cellular memory traces created in synaptic connections of "engram cells" that are specific for a given memory. Combined molecular genetic/behavioral studies using Drosophila have uncovered a complex system of cellular active-forgetting pathways within engram cells that is regulated by dopamine neurons and involves dopamine-nitric oxide co-transmission and reception, endoplasmic reticulum Ca 2+ signaling, and cytoskeletal remodeling machinery regulated by small GTPases. Some of these molecular cellular mechanisms have already been found to be conserved in mammals. Interestingly, some pathways independently regulate forgetting of distinct memory types and temporal phases, suggesting a multi-layering organization of forgetting systems. In mammals, active forgetting also involves modulation of memory trace synaptic strength by altering AMPA receptor trafficking. Furthermore, active-forgetting employs network level mechanisms wherein non-engram neurons, newly born-engram neurons, and glial cells regulate engram synapses in a state and experience dependent manner. Remarkably, there is evidence for potential coordination between the network and cellular level forgetting mechanisms. Finally, subjects with several neuropsychiatric diseases have been tested and shown to be impaired in active forgetting. Insights obtained from research on active forgetting in animal models will continue to enrich our understanding of the brain dysfunctions that occur in neuropsychiatric diseases.

biochemistry & molecular biology,neurosciences,psychiatry

What problem does this paper attempt to address?

The paper primarily explores the mechanism of "active forgetting" and its role in neuropsychiatric disorders. Specifically:

1. **Research Background**: The brain not only needs to form and store memories but also requires "active forgetting" to enhance behavioral flexibility and remove irrelevant information. However, in some neuropsychiatric disorders, the active forgetting mechanism is impaired, leading to intrusive memories, distressing thoughts, and unwanted impulses.

2. **Molecular and Cellular Mechanisms**: Research has found that the active forgetting mechanism is achieved by degrading or masking molecular and cellular memory traces in synaptic connections. These traces exist in specific memory cells (engram cells). Through molecular genetics and behavioral studies, particularly using the fruit fly model, scientists have revealed a complex set of cellular active forgetting pathways. These pathways are regulated by dopamine neurons and involve dopamine-nitric oxide cotransmission, endoplasmic reticulum calcium signaling, and cytoskeletal remodeling regulated by small GTPases.

3. **Network-Level Mechanisms**: Beyond the cellular level, active forgetting also involves network-level mechanisms, where non-memory cells, newly formed memory cells, and glial cells regulate the synapses of memory cells in a state- and experience-dependent manner.

4. **Association with Neuropsychiatric Disorders**: Many patients with neuropsychiatric disorders exhibit impaired active forgetting abilities. For example, patients with post-traumatic stress disorder (PTSD) are affected by the inability to effectively forget traumatic event memories; addicts have enhanced memories of addiction-related cues; patients with anxiety, depression, attention deficit hyperactivity disorder (ADHD), and obsessive-compulsive disorder (OCD) also show varying degrees of active forgetting deficits.

In summary, this paper aims to understand the mechanism of active forgetting and its role in neuropsychiatric disorders, providing new perspectives and potential targets for treating these diseases.